Examkin

Question

Difficulty: MediumInfectious Diseases

A 65-year-old man presents to the outpatient clinic with a 4-day history of a productive cough, fevers, and progressively worsening shortness of breath. His medical history is significant for hypertension and type 2 diabetes mellitus, for which he takes lisinopril and metformin. His temperature is 38.4°C (101.1°F), blood pressure is 132/82 mm Hg, pulse is 98/min, and respiratory rate is 22/min. Pulse oximetry shows an oxygen saturation of 94% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. A chest radiograph demonstrates a dense consolidation in the right lower lobe. The physician determines the patient is stable for outpatient management. Which of the following is the most appropriate empiric pharmacotherapy for this patient?

  1. A
    Amoxicillin monotherapy
  2. B
    Azithromycin monotherapy
  3. Amoxicillin-clavulanate and azithromycinAnswer
  4. D
    Ciprofloxacin monotherapy
  5. E
    Piperacillin-tazobactam and vancomycin

Answer

Amoxicillin-clavulanate and azithromycin
The correct answer provides the recommended combination therapy for an outpatient with community-acquired pneumonia (CAP) who has significant medical comorbidities (such as type 2 diabetes mellitus). According to current clinical guidelines, outpatients with comorbidities (e.g., chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancy; or asplenia) require expanded empiric coverage. This is typically achieved with combination therapy consisting of a beta-lactam (such as amoxicillin-clavulanate or cefpodoxime) PLUS a macrolide (such as azithromycin) or doxycycline. Alternatively, monotherapy with a respiratory fluoroquinolone (such as levofloxacin or moxifloxacin) can be used. The beta-lactam provides robust coverage against typical pathogens (e.g., Streptococcus pneumoniae, Haemophilus influenzae), while the macrolide provides coverage against atypical organisms (e.g., Mycoplasma pneumoniae, Chlamydia pneumoniae).

Step-by-Step Solution

1
Diagnose the patient's condition based on clinical presentation.
The patient has community-acquired pneumonia (CAP), evidenced by fever, productive cough, crackles, and a focal lobar consolidation on chest radiograph.
Establishing the correct infectious syndrome is required before selecting empiric antimicrobial therapy.
2
Stratify the patient's risk and determine the appropriate setting of care.
The patient has stable vital signs and oxygenation, permitting outpatient treatment. However, he has significant comorbidities (type 2 diabetes mellitus, hypertension).
The presence of comorbidities alters the expected pathogen profile and resistance patterns, dictating a different empiric antibiotic strategy compared to healthy individuals.
3
Select the appropriate empiric antibiotic regimen for an outpatient with CAP and comorbidities.
The recommended regimen is a beta-lactam (e.g., amoxicillin-clavulanate) combined with a macrolide (e.g., azithromycin) or doxycycline, OR monotherapy with a respiratory fluoroquinolone.
This strategy ensures adequate coverage against common typical pathogens (including macrolide-resistant Streptococcus pneumoniae and beta-lactamase producing Haemophilus influenzae) as well as atypical pathogens (Mycoplasma, Chlamydia, Legionella).

Key Concept

Empiric antibiotic selection for community-acquired pneumonia (CAP) in outpatients with comorbidities
Rate this question

Topics

Infectious Diseases

More questions from this topic